Cargando…
Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sources
Clinical implementation of pharmacogenomics (PGx) is slow. Previous studies have identified some inconsistencies among clinical PGx recommendations, but the prevalence and types of inconsistencies have not been comprehensively analyzed among major PGx guidance sources in the U.S. PGx recommendations...
Autores principales: | Shugg, Tyler, Pasternak, Amy L., London, Bianca, Luzum, Jasmine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603298/ https://www.ncbi.nlm.nih.gov/pubmed/33145028 http://dx.doi.org/10.1038/s41525-020-00156-7 |
Ejemplares similares
-
Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement?
por: Luzum, Jasmine A., et al.
Publicado: (2016) -
Survey of U.S. Public Attitudes Towards Pharmacogenetic Testing
por: Haga, Susanne B., et al.
Publicado: (2011) -
The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S
por: Haga, Susanne B.
Publicado: (2023) -
Broad and Inconsistent Muscle Food Classification Is Problematic for Dietary Guidance in the U.S.
por: Gifford, Cody L., et al.
Publicado: (2017) -
Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications
por: Zhang, Frederick, et al.
Publicado: (2019)